Filing Details
- Accession Number:
- 0001144204-13-049226
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-04 16:30:30
- Reporting Period:
- 2013-08-30
- Filing Date:
- 2013-09-04
- Accepted Time:
- 2013-09-04 16:30:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 892160 | Derma Sciences Inc. | DSCI | Surgical & Medical Instruments & Apparatus (3841) | 232328753 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1240335 | E John Yetter | Derma Sciences Inc 214 Carnegie Center, Suite 300 Princeton NJ 08540 | Evp, Finance & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-08-30 | 500 | $14.01 | 58,384 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-03 | 11,600 | $14.17 | 46,784 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan.
- Represents the weighted average sale price of multiple transactions with a range of prices between $14.00 to $14.05. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price of multiple transactions with a range of prices between $14.00 to $14.30. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
